Viromed Medical AG | WebDisclosure

Switch to English

10816	Sociétés
234400	Mots-clés
163253	Articles
125406	Communiqués

Accueil
Sociétés
Viromed Medical AG

COMMUNIQUÉ DE PRESSE

publié le 08/05/2026 à 19:12, il y a 3 mois 2 jours

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Viromed Medical AG missed revenue forecast for 2025 but saw significant growth, achieving a positive result. The company has revised its forecast for 2026 due to market launch delays

Revenue Forecast Growth Viromed Medical AG Forecast Revision Positive Result
BRÈVE

publiée le 21/04/2026 à 09:17, il y a 3 mois 19 jours

Viromed Medical AG commence la production de ViroCAP® pour HELLMUT RUCK GmbH

Viromed Medical AG Technologie Du Plasma Froid ViroCAP® HELLMUT RUCK GmbH Marché De La Podologie
BRÈVE

publiée le 21/04/2026 à 09:17, il y a 3 mois 19 jours

Viromed Medical AG Begins Production of ViroCAP® for HELLMUT RUCK GmbH

Viromed Medical AG Cold Plasma Technology ViroCAP® HELLMUT RUCK GmbH Podiatry Market
COMMUNIQUÉ DE PRESSE

publié le 21/04/2026 à 09:12, il y a 3 mois 19 jours

Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH
Viromed Medical AG starts production of the OEM version of ViroCAP® for HELLMUT RUCK GmbH, marking an exclusive partnership in podiatry with access to over 120,000 customers and preparations for further international sales cooperations

Partnership Podiatry Viromed Medical AG ViroCAP OEM Version
BRÈVE

publiée le 23/03/2026 à 11:49, il y a 4 mois 18 jours

Viromed Medical AG obtient un financement pour ses innovations dans le domaine du plasma froid

Viromed Medical AG Technologie Du Plasma Froid Innovation En Médecine Financement Du Ministère Fédéral Développement De PulmoPlas®
BRÈVE

publiée le 23/03/2026 à 11:49, il y a 4 mois 18 jours

Viromed Medical AG Secures Funding for Cold Plasma Innovations

Viromed Medical AG Cold Plasma Technology Innovation In Medicine Federal Ministry Funding PulmoPlas® Development
COMMUNIQUÉ DE PRESSE

publié le 23/03/2026 à 11:44, il y a 4 mois 18 jours

Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology
Viromed Medical AG receives funding approval from the Federal Ministry of Research, Technology and Space for the development of cold plasma technology

Research And Development Viromed Medical AG Scientific Innovation Cold Plasma Technology Funding Approval
BRÈVE

publiée le 19/03/2026 à 09:05, il y a 4 mois 22 jours

Viromed Medical AG Appoints Anna Heinen to Supervisory Board

Supervisory Board Corporate Strategy Viromed Medical AG Cold Plasma Technology Anna Heinen
BRÈVE

publiée le 19/03/2026 à 09:05, il y a 4 mois 22 jours

Viromed Medical AG nomme Anna Heinen au conseil de surveillance

Stratégie D'entreprise Conseil De Surveillance Viromed Medical AG Technologie Du Plasma Froid Anna Heinen
COMMUNIQUÉ DE PRESSE

publié le 19/03/2026 à 09:00, il y a 4 mois 22 jours

Viromed Medical AG: Anna Heinen appointed to the Supervisory Board
Anna Heinen appointed to the Supervisory Board of Viromed Medical AG, bringing expertise in corporate strategy and governance. She succeeds Frank Otto

Governance Supervisory Board Corporate Strategy Viromed Medical AG Anna Heinen

Les Echos

Publié le 10/08/2026 à 18:00, il y a 2 heures 18 minutes

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Publié le 10/08/2026 à 18:00, il y a 2 heures 18 minutes

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Publié le 10/08/2026 à 17:45, il y a 2 heures 33 minutes

Weekly share buyback
Publié le 10/08/2026 à 17:45, il y a 2 heures 33 minutes

Déclaration hebdomadaire de rachat d'actions
Publié le 10/08/2026 à 11:53, il y a 8 heures 24 minutes

GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 10/08/2026 à 15:30, il y a 4 heures 48 minutes

Silver Spruce Resources, Inc. Announces New Chief Financial Officer
Publié le 10/08/2026 à 15:25, il y a 4 heures 53 minutes

Gemdale Gold Intersects 5.19m at 14.01 g/t Au within 110m at 1.18 g/t Au at the Pontio Gold Project, Finland
Publié le 10/08/2026 à 14:30, il y a 5 heures 48 minutes

NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Publié le 10/08/2026 à 13:30, il y a 6 heures 48 minutes

Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Publié le 10/08/2026 à 13:00, il y a 7 heures 18 minutes

Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada

Voir tout ACCESSWIRE

EQS Group

Publié le 10/08/2026 à 19:35, il y a 43 minutes

Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Publié le 10/08/2026 à 19:00, il y a 1 heure 18 minutes

PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026
Publié le 10/08/2026 à 18:29, il y a 1 heure 49 minutes

Fuller, Smith & Turner PLC: Director/PDMR Shareholdings
Publié le 10/08/2026 à 17:50, il y a 2 heures 28 minutes

Disclosure according to Article 5(1)(b) of the EU Regulation No. 596/2014 and Article 2(3) of the Delegated EU Regulation No. 2016/1052 - 1st Interim Report
Publié le 10/08/2026 à 17:38, il y a 2 heures 40 minutes

PATRIZIA delivers strong earnings growth with EUR 42.7m EBITDA (+46.6% y-o-y) in H1 2026